Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy

被引：4
|
作者：
Pinto, Valeria [1 ]
Balocco, Manuela [1 ]
Ambaglio, Ilaria [2 ]
Derchi, Giorgio [3 ]
Malcovati, Luca [2 ]
Forni, Gian Luca [1 ]
机构：
[1] Osped Galliera, Ematol Ctr Microcitemia & Anemie Congenite, Via Volta 6, I-16128 Genoa, Italy
[2] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Dept Hematol Oncol, I-27100 Pavia, Italy
[3] Osped Galliera, Unit Cardiol, Genoa, Italy
来源：
CLINICAL CASE REPORTS | 2015年 / 3卷 / 11期
关键词：
Deferiprone; desferal; heart failure; iron chelation; myelodysplastic syndromes;
D O I：
10.1002/ccr3.407
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Key Clinical Message Patients with transfusion-dependent myelodysplastic syndromes (MDS) have an increased risk of cardiac events, due to both chronic anemia and iron overload. Here, we report the recovery of cardiac function after an intensive iron chelation therapy in a MDS patient who had developed heart failure due to iron overload.
引用
收藏
页码：952 / 954
页数：3
相关论文
共 50 条
  • [1] IRON CHELATION THERAPY WITH THE DEFERIPRONE PLUS DEFEROXAMINE REGIMEN USED IN PATIENTS WITH THALASSEMIA SAFELY AND EFFECTIVELY REVERSED IRON OVERLOAD-RELATED HEART FAILURE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME
    Pinto, V.
    Balocco, M.
    Quintino, S.
    Lamagna, M.
    Carrara, P.
    Forni, G. L.
    HAEMATOLOGICA, 2015, 100 : 105 - 106
  • [2] Iron chelation therapy in patients with transfusion-dependent myelodysplastic syndrome
    Mast, Alan E.
    Field, Joshua J.
    TRANSFUSION, 2012, 52 (10) : 2078 - 2080
  • [3] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [4] A RISK EQUATION TO ESTIMATE IRON OVERLOAD-RELATED COMPLICATION RATES BASED ON ADHERENCE RATES OF IRON CHELATION THERAPY IN TRANSFUSION-DEPENDENT THALASSEMIA
    Huang, V. W.
    Kuizenga, P.
    Barbier, M.
    Kessabi, S.
    VALUE IN HEALTH, 2016, 19 (03) : A250 - A251
  • [5] Guidelines on iron chelation therapy in patients with myelodysplastic syndrome and transfusion iron overload
    Gattermann, N.
    LEUKEMIA RESEARCH, 2007, 31 : S15 - S16
  • [6] Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
    Roy, Noemi B. A.
    Myerson, Saul
    Schuh, Anna H.
    Bignell, Patricia
    Patel, Roger
    Wainscoat, Jim S.
    McGowan, Simon
    Marchi, Emanuele
    Atoyebi, Wale
    Littlewood, Tim
    Chacko, Joseph
    Vyas, Paresh
    Killick, Sally B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 521 - 524
  • [7] EFFECT OF CHELATION ON CARDIAC IRON OVERLOAD IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA
    Pines, Morgan
    Sheth, Sujit
    Kleinert, Dorothy
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [8] IRON CHELATION THERAPY IMPROVES OXIDATIVE DNA DAMAGE IN HEMATOPOIETIC CELLS DERIVED FROM TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROME
    Kobune, Masayoshi
    Kikuchi, Shohei
    Iyama, Satoshi
    Takada, Kohichi
    Murase, Kazuyuki
    Ono, Kaoru
    Horiguchi, Hiroto
    Kamihara, Yusuke
    Hayashi, Tsuyoshi
    Sato, Tsutomu
    Miyanishi, Koji
    Sato, Yasushi
    Takimoto, Rishu
    Kato, Junji
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E98 - E98
  • [9] Development of an adherence to Iron-Chelation Therapy measure through a qualitative study: patient and caregiver perspectives in transfusion-dependent anemias and myelodysplastic syndrome
    Lasch, Kathryn E.
    Horodniceanu, Erica G.
    Bal, Vasudha
    Cote, Isabelle
    Dorgan, Amy
    Malet, Isabelle
    QUALITY OF LIFE RESEARCH, 2014, 23 : 105 - 105
  • [10] Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion-Dependent Thalassemia
    Lal, Ashutosh
    Sweeters, Nancy
    Ng, Vivian
    Foote, Drucilla
    Evans, Patricia
    Neumayr, Lynne
    Kurio, Gregory
    Harmatz, Paul
    Porter, John B.
    Vichinsky, Elliott
    BLOOD, 2010, 116 (21) : 1732 - 1733
12345